Commission Implementing Regulation (EU) 2026/398 of 18 February 2026 amending Implementing Regulation (EU) No 686/2012 as regards the allocation to Member States, for the purposes of the renewal procedure, of the evaluation of metconazole and quinolin-8-ol
Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗
Part E of the Annex to Implementing Regulation (EU) No 686/2012 is amended as follows: (1) the following entry is inserted after the entry for ‘Metalaxyl-M’: Active substance Rapporteur Member State Co-rapporteur Member State ‘Metconazole SE BE’ (2) the following entry is inserted after the entry for ‘Pyriproxyfen’: Active substance Rapporteur Member State Co-rapporteur Member State ‘Quinolin-8-ol NL BE’
This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .
Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.